Wegovy is approved for chronic weight management in obesity or overweight with comorbidities, and as of March 2024, for cardiovascular risk reduction in adults with established cardiovascular disease and either obesity or overweight
This reliance on EtO presents a challenge in balancing the benefits of effective sterilization against the potential health risks associated with its emissions
Physiologic limits to renal uric acid excretion promote hyperuricemia
Alves R, Mota S, Silva S, Rodrigues F, Brown CP, Henriques AJ, Casal M, Paiva M
However, the IGF-I gene expression decreased with increasing severity of MASLD, suggesting that reductions of hepatic IGF-I production in patients with MASLD may be related to the severity of the damaged hepatocytes
Clean label THERASCIENCE